Consumer Information for: MYLAN-RILUZOLE
Consumer Information
Information about the product including what the product is used for, dosage, warnings, proper use and side effects. This summary will not tell you everything about the product. Contact your healthcare professional if you have any questions about the product.
What the medication is used for
The treatment of amyotrophic lateral sclerosis (ALS), a disease of the brain and spinal cord that causes muscle weakness and wasting, and eventually paralysis.
What it does
MYLAN-RILUZOLE is not a cure for ALS; although it may
prolong life by an average time of about 3 months.
There is no evidence that riluzole has an effect on the symptoms
of ALS, so you are not likely to feel a difference or see a
noticeable change in your condition during treatment.
When it should not be used
- If you have liver problems
- If you have an allergy or sensitivity to riluzole or any of the other tablet ingredients (See “What the nonmedicinal ingredients are” in this section)
- If you are pregnant or breastfeeding
What the medicinal ingredient is
Riluzole
What the non-medicinal ingredients are
Calcium hydrogen phosphate anhydrous, croscarmellose sodium, silica colloidal anhydrous, magnesium stearate, microcrystalline cellulose. Coating: hydroxypropyl methylcellulose, polyethylene glycol and titanium dioxide.
What dosage form it comes in
Film-Coated Tablets, 50 mg
Warnings and precautions
Some people may experience liver injury while taking MYLANRILUZOLE
that is most often mild and temporary. Your doctor
should periodically test the function of your liver while you are
taking MYLAN-RILUZOLE. Depending on these tests results,
your doctor may decide that additional liver evaluation is
required. Signs of liver injury for patients to watch for are listed in
section “SIDE EFFECTS AND WHAT TO DO ABOUT
THEM”.
BEFORE you use MYLAN-RILUZOLE talk to your doctor or
pharmacist if:
- You have ever had any allergic reactions to medications, food etc.
- You have liver problems
- You are taking other drugs that may be toxic to the liver
- You are or think you are pregnant or if you may become pregnant
- You are breastfeeding
Because riluzole can, rarely, decrease white blood cells counts, let
your doctor know if you experience fever, so the decision can be
made as to whether further investigation is needed.
MYLAN-RILUZOLE may make you feel dizzy or sleepy. If you
experience these feelings do not drive a vehicle or use machinery.
MYLAN-RILUZOLE must not be given to anyone other than the
person for whom it was prescribed.
Interactions with this medication
Drugs that may interact with MYLAN-RILUZOLE include:
- Drugs that may be toxic to the liver, such as allopurinol,
methyldopa or sulfasalazine.
- Drugs or substances that may have an effect on the elimination of MYLAN-RILUZOLE from the body, such as caffeine, the antibiotics quinolones and rifampicin, theophylline, amitriptyline, omeprazole, cigarette smoke and charcoal-broiled food.
Proper use of this medication
Usual dose
The effect of MYLAN-RILUZOLE therapy is dependent upon
taking it continuously at regular intervals, as directed. It is
important that you follow your doctor’s instructions about taking
MYLAN-RILUZOLE.
The recommended dose is 1 tablet (50 mg) every 12 hours.
MYLAN-RILUZOLE should be taken 1 hour before meals or 2
hours after meals. You should take this medicine on a regular
basis and at the same time of the day (e.g., in the morning and
evening) each day.
Overdose
There is no benefit in increasing the dose above two tablets per day. In fact, you may experience more side effects. Any medication taken in excess can have serious consequences.
If you have taken too much MYLAN-RILUZOLE, immediately see your doctor or go to your nearest hospital emergency department. Show the doctor your bottle of tablets. Do this even if there are no signs of discomfort or poisoning.
Missed Dose
If you miss or skip a dose of MYLAN-RILUZOLE, take your medicine at the next scheduled time. Do not take any extra tablets to make up for those you missed.
Side effects and what to do about them
The most common side effects are mild, temporary liver injury, weakness, fatigue, dizziness and stomach upset. Some less common side effects are: vomiting, mouth sores, increase or loss of appetite, eczema, diarrhea, irregular or fast heart beat and swelling of the hands, feet or legs. MYLAN-RILUZOLE may have other side effects which have not been described here. If you notice any change in your health while taking MYLANRILUZOLE, tell your doctor.
Symptom / effect | Talk with your doctor or pharmacist Only if severe | Talk with your doctor or pharmacist In all cases | Stop taking drug and seek immediate emergency medical attention |
---|---|---|---|
Common | |||
Dizziness | ✔ | ||
Fatigue | ✔ | ||
Stomach upset | ✔ | ||
Weakness | ✔ | ||
Uncommon | |||
Depressed mood | ✔ | ||
Diarrhea | ✔ | ||
Eczema | ✔ | ||
Fever | ✔ | ||
Irregular or fast heart beat | ✔ | ||
Loss of appetite | ✔ | ||
Mouth sores | ✔ | ||
Signs of possible liver problems (with symptoms such as: dark urine, a yellow discolouring of the skin or sclera (the white of your eye), itchiness, nausea, vomiting, loss of appetite, general discomfort, tiredness, or abdominal swelling) | ✔ | ||
Swelling of hands feet or legs | ✔ | ||
Vomiting | ✔ | ||
Respiratory problems (dry cough, and/or difficulty in breathing) | ✔ |
This is not a complete list of side effects. For any unexpected effects while taking MYLAN-RILUZOLE, contact your doctor or pharmacist.
How to store
MYLAN-RILUZOLE should be stored in well-closed, light
resistant containers at controlled room temperature (15°C to
30°C).
MYLAN-RILUZOLE must be kept out of the reach of
children.
Reporting side effects
You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:
- Report online at www.healthcanada.gc.ca/medeffect
- Call toll-free at 1-866-234-2345
- Complete a Canada Vigilance Reporting Form and:
- Fax toll-free to 1-866-678-6789, or
- Mail to: Canada Vigilance
Program
Health Canada
Postal Locator 0701E
Ottawa, ON K1A 0K9
Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffectTM Canada Web site at www.healthcanada.gc.ca/medeffect.
NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.
More information
NOTE: This CONSUMER INFORMATION leaflet provides you
with the most current information at the time of printing.
For the most current information, the Consumer Information
leaflet plus the full Monograph, prepared for health professionals
can be obtained at www.mylan.ca or by contacting the sponsor,
Mylan Pharmaceuticals ULC at: 1-800-575-1379.
This leaflet was prepared by :
Mylan Pharmaceuticals ULC
Toronto, ON M8Z 2S6
Prepared on: July 25, 2012
Related Drug Products
Product name | DIN | Company name | Active ingredient(s) & strength |
---|---|---|---|
CESAMET | 02312263 | BAUSCH HEALTH, CANADA INC. | NABILONE 0.25 MG |
CESAMET | 02256193 | BAUSCH HEALTH, CANADA INC. | NABILONE 0.5 MG |
CESAMET | 00548375 | BAUSCH HEALTH, CANADA INC. | NABILONE 1 MG |